Roger Lo, a professor of medicine, dermatology and molecular and medical pharmacology at the David Geffen School of Medicine at UCLA, has received a $1 million “All-Star” grant from the V Foundation to develop strategies to prevent relapse in patients with advanced melanoma by targeting drug resistance before it takes root.
Nicholas M. Jaidar was named senior administrator for oncology at the Department of Oncology at the Johns Hopkins University School of Medicine and the Johns Hopkins Hospital.
Phyllis Harris was appointed chief legal and risk officer of American Cancer Society, effective June 23.
The University of Cincinnati Cancer Center, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Jabez Biosciences are partnering to open a new phase I clinical trial studying JBZ-001, a potential new treatment for acute myeloid leukemia.
RWJBarnabas Health and Rutgers Cancer Institute officially opened the doors of the 12-story, 520,000 square-foot, state-of-the-art Jack & Sheryl Morris Cancer Center—the state’s only freestanding, comprehensive cancer hospital, one of just 13 in the nation.
Yuman Fong, chair of the Department of Surgery at City of Hope, delivered the Lister Legacy Lecture at the triennial conference of The Royal College of Surgeons of Edinburgh. This presentation honors the long-term impact of Baron Joseph Lister, who brought antiseptic techniques to the practice of surgery.
Ric Anderson was elected chair of the Fred Hutchinson Cancer Center’s board of directors, and Eduardo Peñalver was named vice chair, effective July 1.xxx:moreAnderson is the co-founder and ch
Matt Kozlovac was named the inaugural executive director of Man Up to Cancer, a national nonprofit dedicated to providing social and emotional support for men facing cancer.
Peter Voorhees was promoted to associate director of clinical research and will oversee clinical research for Atrium Health Wake Forest Baptist Comprehensive Cancer Center, as well as all processes related to clinical protocol and data management and protocol review and monitoring system.
UPMC Hillman Cancer Center physician scientist and melanoma researcher Yana Najjar, is the 2025 recipient of the Sy Holzer Endowed Immunotherapy Research Award to advance innovative research in cancer immunotherapy.
